In vitro biological characteristics of human cord blood-derived megakaryocytes

Annals of the Academy of Medicine Singapore

Volumn 33, Issue 5, 2004, Pages 570-575

  Sun, Li ^a   Tan, P ^a   Yap, C ^a   Hwang, W ^a   Koh, L P ^a   Lim, C K ^a   Aw, S E ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

CB; CD34+ cells; Differentiation and maturation; Megakaryocytes

Indexed keywords

ADENOSINE DIPHOSPHATE; CD34 ANTIGEN; COLLAGEN; GLYCOPROTEIN; INTERLEUKIN 3; MONOCLONAL ANTIBODY; NOTCH1 RECEPTOR; PADGEM PROTEIN; RNA; STEM CELL FACTOR; THROMBOPOIETIN;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MICROSCOPY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; THROMBOCYTE ACTIVATION; UMBILICAL CORD BLOOD;

EID: 10344246564     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Thomas ED. Bone marrow transplantation: a review. Semin Hematol 1999;36:95-103.
2. Ikehara S. A new concept of stem cell disorders and their new therapy. J Hematother Stem Cell Res 2003;12:643-53.
3. Sykes M, Sachs DH. Bone marrow transplantation as a means of inducing tolerance. Semin Immunol 1990;2:401-17.
4. Barker JN, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer. Nat Rev Cancer 2003;3:526-32.
5. Wagner JE. Umbilical cord blood stem cell transplantation: current status and future prospects. J Hematother 1993;2:225-8.
6. Michel G, Rocha V, Chevret S, Arcese W, Chan KW, Filipovich A, et al (Eurocord Group). Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood 2003;102:4290-7.
7. Sanz MA, Sanz GF. Unrelated donor umbilical cord blood transplantation in adults. Leukemia 2002;16:1984-91.
8. White J. Anatomy and structure organization of the platelets. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: JB Lippincott Co, 1994:397-413.
9. Marcus AJ, Safier LB, Kaminski WE, Islam N, Hajjar KA, Jendraschak E, et al. Principles of thromboregulation: control of platelet reactivity in vascular disease. Adv Prostaglandin Thromboxane Leukot Res 1995;23:413-8.
10. Wright J. The origin and nature of blood platelets. Boston Med Surg J 1906;154:643-5.
11. Bradly JM, Scurfield G. The mechanisms of platelet release. Blood 1980;56:996-9.
12. Bradly JM, Haller CJ. Fate of senescent megakaryocytes in the bone marrow. Br J Haematol 1983;53:277-87.
13. Gewirtz AM. Megakaryopoiesis: the state of art. Thromb Hemost 1995;74:204-9.
14. Majka M, Baj-Krzyworzeka M, Kijoski J, Reca R, Ratajczak J, Ratajczak MZ. In vitro expansion of humam megakaryocytes as a tool for studying megakaryocytic development and function. Platelets 2001;12:325-32.
15. Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-8.
16. Kaushansky K, Lok S, Holly RD, Broudy VC, Lin N, Bailey MC, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369:568-71.
17. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-31.
18. Kaushansky K, Broudy VC, Lin N, Jorgensen MJ, McCarty J, Fox N, et al. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci U S A 1995;92:3234-8.
19. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995;85:1719-26.
20. Williams L, Pipia G, Datta N, Long M. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood 1998;91:4118-26.
21. Henschler L, Rebulla L, Sirchia G. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Haematologica 2000;85:25-31.
22. Mathur A, Hong Y, Martin J, Erusalimsky J. Megakaryocytic differentiation is accompanied by a reduction in cell migratory potential. Br J Haematol 2001;112:459-65.
23. Schipper LF, Brand A, Reniers N, Melief CJ, Willemze R, Fibbe WE. Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol 2003;31:324-30.
24. Shaw PH, Gilligan D, Wang XM, Thall PF, Corey SJ. Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system. Biol Blood Marrow Transplant 2003;9:151-6.
25. de Alarcon PA, Graeve JL. Analysis of megakaryocyte ploidy in fetal bone marrow biopsies using a new adaptation of the feulgen technique to measure DNA content and estimate megakaryocyte ploidy from biopsy specimens. Pediatr Res 1996;39:166-70.
26. Ma DC, Sun YH, Zuo W, Chang KZ, Chu ZZ, Liu YG. CD34+ cells derived from fetal liver contained a high proportion of immature megakaryocytic progenitor cells. Eur J Haematol 2000;64:304-14.
27. Italiano Jr JE, Shivdasani RA. Megakaryocytes and beyond: the birth of platelates. J Thrombo Haemostasis 2003;1:1174-82.
28. Sun L, Quah TC, Lee BW. Expression of an early B cell And NK cell markers in acute megakaryocytic leukemia. Cancer Res Therapy Control 1994;4:31-7.
29. Karanu FN, Murdock B, Gallacher L, Wu DM, Koremoto M, Sakano S, et al. The Notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000;192:1365-72.
30. Karanu FN, Murdock B, Tomiyoki M, Ohno M, Koremoto M, Gallacher L, et al. Human homologue of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood 2001;97:1960-7.
31. Tan DTH, Liu YP, Sun L. Flow cytmetric analysis of DNA content in primary and secondary pterygia. Invst Ophtol Vis Sci 2000;41:1684-6.
32. Hagberg IA, Lyberg T. Evaluation of circulating platelet-leukocyte conjugates: a sensitive flow cytometric assay well suited for clinical studies. Platelets 2000;11:151-60.
33. Alexander WS, Mauer AB, Novak U, Harrison-Smith M. Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. EMBO J 1996;15:6531-40.
34. Rojnuckrin P, Drachman JG, Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocyte: Role in endomitosis. Blood 1999;94:1237-82.
35. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002;21:3359-67.
36. Lam LT, Ronchini C, Norton J, Capobiaco AJ, Breanick EH. Suppression of erythoid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1. J Biol Chem 2000;275:19676-84.
37. Singh N, Philips RA, Iscove NN, Egan SE. Expression of receptors, notch ligands, and fringe genes in haematopoiesis. Exp Hematol 2000;28:527-34.
38. Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, et al. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. J Cell Physiol 2002;190:109-19.
39. Iwasaki H, Mizuno S, Wells RA, Cantor AB, Watanabe S, Akashi K. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/ erythrocyte lineages. Immunity 2003;19:451-62.
40. Nagata Y, Muro Y, Todokoro K. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis. J Cell Biol 1997;139:449-57.
41. Vitrat N, Chen-Solal K, Pique C, LeCouedic JP, Norol F, Larsen AK, et al. Endomitosis of human megakaryocytes are due to abortive mitosis. Blood 1998;91:3711-23.
42. Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: the megakaryocyte example. J Cell Physiol 2002;190:7-20.
43. Matsumura I, Tanaka H, Kawasaki A, Odajima J, Daino H, Hashimoto K, et al. Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of human thrompoietin-dependent hematopoietic cell line. J Biol Chem 2000;275:5553-9.
44. Cip1/Waf1 in cell-cycle exit of endomitotic megakaryocytes. Blood 2001;98:3274-82.
45. Carow CE, Fox NE, Kaushansky K. Kinetics of endomitosis in primary murine megakaryocytes. J Cell Physiol 2001;188:291-303.
46. Geddis AE, Kaushansky K. Megakaryocytes express functional aurora-B kinase in endomitosis. Blood 2004;May 6. (Epub ahead of print)
47. Levin RF, Olsen TA, Shoff PK, Willer MK, Weissman LE. Mature micromegakaryocytes: An unusual developmental pattern in terms infants. Br J Haemtol 1996;94:391-9.
48. Bornstein R, Garcia-Vale J, Gilsanz F, Auray C, Cales C. Cord blood megakaryocytes do not complete maturation, as indicated by impaired establishment of endomitosis and low expression of G1/S cyclins upon thrombopoietin-induced differentiation. Br J Haematol 2001;114:458-65.
49. van Geet C. Thrombopoiesis: new concepts. Verh K Acad Geneeskd Belg 2004;66:5-24.